Helander H F, Simonsson M, Sundler F, Rutgersson K, Helander K G, Eriksson S
AB Hässle, Mölndal, Sweden.
Virchows Arch A Pathol Anat Histopathol. 1990;417(4):305-9. doi: 10.1007/BF01605781.
Sixty patients with duodenal or prepyloric ulcers were given omeprazole (30 or 40 mg o.m.; average period of treatment: 2.9 weeks) or histamine H2-receptor antagonists (cimetidine 400 mg b.i.d. or ranitidine 150 mg b.i.d.; average period of treatment; 3.5 weeks) for a single period ranging between 2 and 6 weeks. At the end of the treatment period fasting plasma gastrin levels were moderately increased in both groups in comparison with the pretreatment values. Endoscopic biopsies were taken from the oxyntic mucosa at the beginning and at the end of the treatment period. Light microscopy of the biopsies was aimed particularly at determining the number of endocrine cells. In addition, the mucosal thickness and the volume densities of the parietal cells, the lamina propria and the gland lumina were measured. There were no significant differences in the endocrine or parietal cell populations, between biopsies taken from the patients before and after treatment with omeprazole or histamine H2-receptor antagonists. The mucosal thickness and the densities of the lamina propria and of the gland lumina remained unaffected by the treatment.
60例十二指肠溃疡或幽门管溃疡患者接受了奥美拉唑治疗(口服30或40毫克,每日一次;平均治疗周期:2.9周)或组胺H2受体拮抗剂治疗(西咪替丁400毫克,每日两次或雷尼替丁150毫克,每日两次;平均治疗周期:3.5周),治疗周期为2至6周。在治疗期末,与治疗前相比,两组患者的空腹血浆胃泌素水平均有中度升高。在治疗开始时和结束时,从胃体黏膜取内镜活检组织。活检组织的光学显微镜检查主要目的是确定内分泌细胞的数量。此外,还测量了壁细胞、固有层和腺腔的黏膜厚度及体积密度。在用奥美拉唑或组胺H2受体拮抗剂治疗前后取自患者的活检组织之间,内分泌细胞或壁细胞数量没有显著差异。黏膜厚度以及固有层和腺腔的密度不受治疗影响。